What was Medigene’s price range in the past 12 months?
Medigene lowest stock price was €0.01 and its highest was €0.12 in the past 12 months.
What is Medigene’s market cap?
Medigene’s market cap is €53.59K.
When is Medigene’s upcoming earnings report date?
Medigene’s next earnings report is estimated for May 14, 2025 (not yet confirmed), which is 536 days ago.
How were Medigene’s earnings last quarter?
Medigene released its earnings results on Aug 14, 2024. The company reported -€0.52 earnings per share for the quarter, beating the consensus estimate of -€0.56 by €0.04.
Is Medigene overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Medigene pay dividends?
Medigene does not currently pay dividends.
What is Medigene’s EPS estimate?
Medigene’s EPS estimate is -0.38.
How many shares outstanding does Medigene have?
Medigene has 14,887,594 shares outstanding.
What happened to Medigene’s price movement after its last earnings report?
Medigene reported an EPS of -€0.52 in its last earnings report, beating expectations of -€0.56. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Medigene?
Currently, no hedge funds are holding shares in DE:MDG1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medigene AG is presently engaged in the liquidation of its residual assets. Its prior endeavors centered on advancing T-cell therapies designed to combat cancer. The company was founded in 1994 and maintains its principal office in Munich, Germany.